Welcome to our dedicated page for Bancroft Fund SEC filings (Ticker: BCV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bancroft Fund Ltd. (BCV) SEC filings page on Stock Titan is designed to organize the Fund’s regulatory disclosures in one place, even though no specific filings are listed in the available data. Bancroft Fund Ltd. is a diversified closed-end management company that operates as a closed-ended equity mutual fund, with an objective of providing income and potential capital appreciation through investments in convertible and equity securities.
For a fund of this type, key U.S. Securities and Exchange Commission documents typically include annual and periodic reports that describe portfolio holdings, investment strategies, risks, and distribution practices. These filings can also provide additional detail on how the Fund’s distribution framework interacts with earnings, realized capital gains, and return of capital, topics that are highlighted in the Fund’s public communications.
On Stock Titan, users can access Bancroft Fund Ltd.’s historical and future SEC filings as they become available from EDGAR, along with AI‑powered summaries. These summaries are intended to explain, in plain language, the main points of lengthy reports, such as how income, net capital gains, and return of capital are reflected in shareholder distributions, or how the Fund describes its investment focus on convertible and equity securities across industries like computer software and services, energy and utilities, and health care.
Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. Using this filings page together with the Fund’s own materials can help users better understand BCV’s regulatory disclosures and how they relate to the Fund’s stated strategy and distribution practices.
Bancroft Fund Ltd. insider trade reported: President and director James A. Dinsmore disclosed buying 220 common shares of Bancroft Fund Ltd. on 12/17/2025 at a price of $21.5 per share. Following this purchase, he beneficially owned a total of 990 common shares, held in direct ownership form. The filing reflects a routine insider acquisition by a senior officer and board member of Bancroft Fund Ltd. (ticker BCV).
Mario J. Gabelli, a director and control person of the investment adviser to Bancroft Fund Ltd (BCV), reported a share sale and updated holdings. On 01/05/2026, 1,300 common shares of Bancroft Fund were sold at $22.255 per share, reported as a disposition. Following this transaction, 25,700 common shares were reported as indirectly owned through Associated Capital Group, Inc. (ACG), and 131,000 common shares were reported as directly owned.
The filing notes that the reported shares reflect the total shares owned by ACG. Gabelli is the Executive Chair and controlling shareholder of ACG, but he has less than a 100% interest in ACG and disclaims beneficial ownership of shares held by ACG that exceed his indirect pecuniary interest.
Ameriprise Financial filed a Schedule 13G reporting a passive stake in Bancroft Fund Ltd. (BCV). As of 09/30/2025, Ameriprise Financial, Inc. reported 306,950 shares, representing 5.3% of the class, with shared voting power of 700 and shared dispositive power of 306,950. Its affiliate, Ameriprise Financial Services, LLC, reported 306,250 shares, also 5.3%, with no voting power and shared dispositive power of 306,250.
The filing is on a Schedule 13G, indicating the shares are held in the ordinary course and not for the purpose of changing or influencing control. Each reporting person disclaims beneficial ownership beyond what is stated.
Saba Capital Management filed Amendment No. 3 to Schedule 13D on Bancroft Fund Ltd. (BCV), reporting beneficial ownership of 355,835 common shares, representing 6.07% of the class. The percentage is based on 5,862,058 shares outstanding as of 3/31/25.
Saba and its affiliates report shared voting and dispositive power over 355,835 shares and no sole power. The filing states an aggregate purchase consideration of approximately $6,366,769. The date of the event requiring the filing is 10/29/2025, and the amendment updates Items 3, 5, and 7. Recent transactions within sixty days are listed in Schedule A.
Mario J. Gabelli filed a Form 4 reporting the sale of 1,000 Bancroft Fund Ltd (BCV) common shares on 10/20/2025 at a price of $23.4265 per share.
Following the reported transaction, the filing lists 131,000 shares held directly and 27,000 shares held indirectly through Associated Capital Group, Inc. (ACG). The note states Mr. Gabelli is Executive Chair and controlling shareholder of ACG and disclaims beneficial ownership of shares held by ACG beyond his indirect pecuniary interest. The form identifies him as a Director and “Control Person of Adviser” to the issuer.
Saba Capital and affiliates report owning 295,200 common shares of Bancroft Fund Ltd., representing 5.04% of the outstanding shares based on 5,862,058 shares. The Schedule 13D/A (Amendment No. 2) was filed to amend Items 3, 5 and 7 and shows the position is held jointly by Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein. Purchase funds came from investor subscriptions, capital appreciation and margin borrowings, and the aggregate purchase cost reported for these shares is approximately $4,983,909. Reported voting and dispositive power is shared, with no sole voting or dispositive power claimed.